The following table presents the Company’s intangible assets at March 31, 2026 (in thousands):


	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Intangible assets:
License and acquired intangibles for RUZURGI®	$	33,569	$	8,639	$	24,930
License and acquired intangibles for FYCOMPA®		158,143		100,838		57,305
License and acquired intangibles for AGAMREE®		48,500		8,764		39,736
Total	$	240,212	$	118,241	$	121,971

The following table presents the Company’s intangible assets at December 31, 2025 (in thousands):


	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Intangible assets:
License and acquired intangibles for RUZURGI®	$	33,569	$	8,059	$	25,510
License and acquired intangibles for FYCOMPA®		158,143		92,931		65,212
License and acquired intangibles for AGAMREE®		48,500		7,548		40,952
Total	$	240,212	$	108,538	$	131,674

The Company amortizes its definite-lived intangible assets using the straight-line method, which is considered the best estimate of economic benefit, over its estimated useful life. The estimated useful life used for this purpose for RUZURGI®, FYCOMPA® and AGAMREE® was approximately 14.5 years, 5 years and 10.5 years, respectively.

The Company recorded approximately $0.6 million in amortization expense related to the license and acquired intangibles for RUZURGI® during each of the three months ended March 31, 2026 and 2025, within selling, general and administrative expenses in the condensed consolidated statements of operations and comprehensive income. The Company recorded approximately $7.9 million in amortization expense related to the license and acquired intangibles for FYCOMPA® during each of the three months ended March 31, 2026 and 2025, respectively, within cost of sales in the condensed consolidated statements of operations and comprehensive income. The Company recorded approximately $1.2 million and $0.9 million in amortization expense related to the license and acquired intangibles for AGAMREE® during the three months ended March 31, 2026 and 2025, respectively, within cost of sales in the condensed consolidated statements of operations and comprehensive income.

The following table presents future amortization expense the Company expects for its intangible assets (in thousands):


2026 (remaining nine months)		29,112
2027		38,815
2028		9,142
2029		7,186
2030		7,186
Thereafter		30,530
Total	$	121,971

At March 31, 2026 and December 31, 2025, the weighted average amortization period remaining for intangible assets was 4.4 years and 4.7 years, respectively.

There were no impairment charges recognized on definite-lived intangibles for the three months ended March 31, 2026 or 2025.